Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results Meeting Abstract


Authors: Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; Hakimi, A. A.; Matulewicz, R.; Funt, S. A.; Bajorin, D. F.; Iyer, G.; Ostrovnaya, I.; Al-Ahmadie, H. A.; Rosenberg, J. E.; Coleman, J.; Teo, M. Y.
Abstract Title: Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
Meeting Title: 2024 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 4 Suppl.
Meeting Dates: 2024 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-02-01
Language: English
ACCESSION: WOS:001266676900241
DOI: 10.1200/JCO.2024.42.4_suppl.645
PROVIDER: wos
Notes: Meeting Abstract: 645 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    344 Coleman
  2. Dean Bajorin
    658 Bajorin
  3. Sherri M Donat
    174 Donat
  4. Gopakumar Vasudeva Iyer
    345 Iyer
  5. Ashley Regazzi
    90 Regazzi
  6. Jonathan Eric Rosenberg
    513 Rosenberg
  7. Abraham Ari Hakimi
    324 Hakimi
  8. Eugene K. Cha
    100 Cha
  9. Samuel Aaron Funt
    137 Funt
  10. Min Yuen   Teo
    105 Teo
  11. Eugene J Pietzak
    116 Pietzak
  12. Alvin Chun chin Goh
    72 Goh
  13. David Henry Aggen
    57 Aggen